Clinical Trials

Title   A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable PancreaticAdenocarcinoma
Description   The purpose of this study is to compare the effects of mFOLFIRINOX (oxaliplatin, irinotecan, and fluorouracil) and gemcitabine plus nab-paclitaxel
IRB Number   16-118
Treatment   Oncology - Pancreatic Cancer
Status   Active
Principal Name   Marcus Tan, MD
Contact Name   Kathleen Ollis

Email Newsletters

Connect With Us